To summarize, prebiotics like PAMK inhibited the development of NASH by reducing liver lipid accumulation, the mRNA expression of liver proinflammatory factors, and serum ALT and AST. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.